10:45 AM EST - Valeant Pharmaceuticals International, Inc. : announced that it has entered into a definitive agreement under which Valeant will acquire Mercury (Cayman) Holdings, the holding company of Amoun Pharmaceutical, for consideration of approximately $800 million U.S., plus contingent payments. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading down $1.18 at $308.87.
